GliomaGen: Conditional Diffusion for Post-Treatment Glioma MRI Generation

GliomaGen is a generative diffusion model tailored for synthesizing post-treatment glioma MRI images based on anatomical masks. It leverages a modified Med-DDPM architecture to create high-fidelity MRI images conditioned on segmented anatomical features.

Model Overview

GliomaGen aims to address data scarcity in post-treatment glioma segmentation tasks by expanding existing datasets with synthetic, high-quality MRI volumes. The model takes anatomical masks as input and generates multi-modal MRI scans conditioned on segmentation labels.

Model Performance

Quantitative Metrics

Modality FID (↓) KID (↓) MS-SSIM (↑)
t1c 55.20 ± 3.74 0.0293 ± 0.0019 0.7647 ± 0.2106
t2w 54.99 ± 3.23 0.0291 ± 0.0010 0.6513 ± 0.2881
t1n 58.46 ± 3.86 0.0305 ± 0.0011 0.7005 ± 0.2585
t2f 70.42 ± 4.17 0.0370 ± 0.0018 0.7842 ± 0.1551

Usage

To use GliomaGen for MRI generation, see the GitHub repository.

BraTS 2024 Adult Post-Treatment Glioma-Synthetic

Alongisde GliomaGen, a synthetic dataset of $N=2124$ MR images is released on HuggingFace.

Downloads last month

-

Downloads are not tracked for this model. How to track
Inference Providers NEW
This model isn't deployed by any Inference Provider. 🙋 Ask for provider support

Evaluation results

  • FID (t1c) on BraTS2024 Adult Post-Treatment Glioma
    self-reported
    55.2028 ± 3.7446
  • FID (t2w) on BraTS2024 Adult Post-Treatment Glioma
    self-reported
    54.9974 ± 3.2271
  • KID (t1c) on BraTS2024 Adult Post-Treatment Glioma
    self-reported
    0.0293 ± 0.0019
  • MS-SSIM (t1c) on BraTS2024 Adult Post-Treatment Glioma
    self-reported
    0.7647 ± 0.2106